Log on / register
Feedback | Support | My details
Outcome of ATP-based tumor chemosensitivity assay directed chemotherapy in heavily pre-treated recurrent ovarian carcinoma.
Sharma S, Neale MH, Di Nicolantonio F, Knight LA, Whitehouse PA, Mercer SJ, Higgins BR, Lamont A, Osborne R, Hindley AC, Kurbacher CM, Cree IA
BMC Cancer 2003 Jul 3, 3:19
[Full text] [PubMed] [Related articles] [Cited on BioMed Central]


printer friendly 
to  [Help]

BioMed Central articles that cite the above article:

1.


Research article    
DNA damage induced by cis- and carboplatin as indicator for in vitro sensitivity of ovarian carcinoma cells
Unger FT, Klasen HA, Tchartchian G, de Wilde RL, Witte I
BMC Cancer 2009, 9:359 (10 October 2009)
[Abstract] [Full text] [PDF] [PubMed] [Related articles]

2.


Research    
Feasibility of chemosensitivity testing in soft tissue sarcomas
Lehnhardt M, Muehlberger T, Kuhnen C, Brett D, Steinau HU, Jafari HJ, Steinstraesser L, Müller O, Homann HH
World Journal of Surgical Oncology 2005, 3:20 (18 April 2005)
[Abstract] [Full Text] [PDF] [PubMed] [Related articles] [Cited on BioMed Central]

3.


Research article    
The in vitro effect of gefitinib ('Iressa') alone and in combination with cytotoxic chemotherapy on human solid tumours
Knight LA, Di Nicolantonio F, Whitehouse P, Mercer S, Sharma S, Glaysher S, Johnson P, Cree IA
BMC Cancer 2004, 4:83 (23 November 2004)
[Abstract] [Full text] [PDF] [PubMed] [Related articles]


This article is also cited by a further 1 article in PubMed Central


You can also check ISI Web of Science for additional citations (subscription required)
printer friendly 
to  [Help]

© 1999-2009 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.